Antibody Therapeutics
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 4.8 | Q2 | 69.9% | 1.003 | Q2 | 83.9% |
| 2024 | 4.5 | Q2 | 71.7% | 1.314 | Q1 | 90.1% |
| 2023 | — | — | 1.345 | Q1 | 91.3% | |
| 2022 | — | — | 1.648 | Q1 | 94.1% | |
| 2021 | — | — | 1.603 | Q1 | 93.8% | |
| 2020 | — | — | 0.579 | Q3 | 70.7% | |
| 2019 | — | — | 0.388 | Q3 | 60.2% | |
| 2018 | — | — | — | 0.0% | ||
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
ISSN
2516-4236
country
UScoverage
2018-2026